[Therapeutic considerations on the hypoglycemic action of buclizine (Postafen)].
D000293:Adolescent; D000328:Adult; D001066:Appetite / Q000187:drug effects*; D001786:Blood Glucose; D001835:Body Weight / Q000187:drug effects*; D005260:Female; D005951:Glucose Tolerance Test; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008297:Male; D010629:Phenformin / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D011236:Prediabetic State / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000494:pharmacology*
D001786:Blood Glucose; D006634:Histamine H1 Antagonists; D007004:Hypoglycemic Agents; D010879:Piperazines; D014149:Tranquilizing Agents; D010629:Phenformin
Considerações terapêuticas sôbre a ação hipoglice-miante da Buclizina (Postafen)